Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05884086

Ataxia GAA-FGF14 - Descriptive Genetic and Clinical Study

Sponsor: Central Hospital, Nancy, France

View on ClinicalTrials.gov

Summary

Cerebellar ataxias of late onset are of undetermined etiology in many cases. A new cause of late-onset cerebellar ataxia was discovered in January 2023 corresponding to an expansion of GAA triplets in intron 1 of the FGF14 gene. However, this cerebellar ataxia is still poorly known and requires further investigations to know its clinical phenotype and its evolution in order to propose a diagnosis and a genetic counseling adapted to patients and families. The objective of our study will be to describe the clinical and genotypic phenotype of patients with GAA-FGF14

Official title: Ataxia GAA-FGF14 - Descriptive Genetic and Clinical Study on Late Onset Ataxia Related to a GAA Expansion in the FGF14 Gene

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2023-05-01

Completion Date

2026-06

Last Updated

2023-06-01

Healthy Volunteers

No

Conditions

Interventions

OTHER

Unknown

no intervention is necessary. Clinical observation and clinical examination only.

Locations (1)

Centre hospitalier régional universitaire

Nancy, France